IL33 and Cognitive impairment: The available studies in these disease models have demonstrated that IL-33/ST2 pathway might inhibit the inflammatory response and reduce cognitive impairment by promoting the polarization of microglia toward the anti-inflammatory M2 phenotype, which may be a reliable therapeutic strategy [2, 30, 80, 88, 92].